Efficacy and Safety of SGLT2 Inhibitors in Heart Failure: Systematic Review and Meta-Analysis
Javed Butler(Jackson Memorial Hospital), Stefan D. Anker(Charité - Universitätsmedizin Berlin), Muhammad Shahzeb Khan(University of Mississippi Medical Center), Stephen J. Greene(Duke Medical Center), Tim Friede(Universitätsmedizin Göttingen), Muthiah Vaduganathan(Brigham and Women's Hospital), Muhammad Usman(Dow University of Health Sciences), Andrew J.S. Coats(The Heart Research Institute), Gerasimos Filippatos(National and Kapodistrian University of Athens)
Cited by 141
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k